Fee Compression And Regulatory Burdens Will Erode Alternative Models
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
22 Jun 25
Updated
09 Aug 25
AnalystLowTarget's Fair Value
US$17.31
17.4% overvalued intrinsic discount09 Aug
US$20.32
1Y
17.5%7D
5.0%